4//SEC Filing
Howard Elizabeth 4
Accession 0001447028-22-000010
CIK 0001447028other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 5:54 PM ET
Size
8.7 KB
Accession
0001447028-22-000010
Insider Transaction Report
Form 4
Howard Elizabeth
Exec. VP & General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2022-01-20$2.81/sh+237,500$667,375→ 237,500 totalExercise: $2.81Exp: 2032-01-20→ Common Shares (237,500 underlying)
Footnotes (1)
- [F1]These stock options will vest and become exercisable 1/48th each month over the four year period.
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeother
Related Parties
1- filerCIK 0001669530
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 5:54 PM ET
- Size
- 8.7 KB